1 items1 sources1 stocks
Investing.com-Nov 8, 03:04 PM
Cabaletta Bio reports phase 1/2 data for autoimmune therapy
Cabaletta Bio reports phase 1/2 data for autoimmune therapy(摘要待生成)
CABAhealthcare
Loading...
Cabaletta Bio reports phase 1/2 data for autoimmune therapy(摘要待生成)